Share Price | Goldline Pharmaceutical Ltd Stock Analysis & Recommendation

Q: Why is Goldline Pharmac falling/rising?

As of 26-May, Goldline Pharmaceutical Ltd's stock price is falling, currently at Rs. 43.95, which represents a decline of Rs. 2.31 or 4.99%. The stock has been on a downward trend, having lost 22.58% over the past week and underperformed its sector by 5.03% today. It opened with a gap down, reflecting a loss of 4.99% right from the start of the trading day. Additionally, the stock has reached a new 52-week low of Rs. 43.95 today.The performance indicators show that Goldline Pharmaceutical is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a significant drop in investor participation, with delivery volume decreasing by 53.75% compared to the 5-day average. This lack of interest from investors contributes to the stock's declining price. Overall, these factors collectively explain the current fall in Goldline Pharmaceutical's stock price.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

3.63 lacs (24.74%) Volume

Shareholding (May 2026)

FII

5.16%

Held by 15 FIIs

DII

7.81%

Held by 0 DIIs

Promoter

57.29%

Why is Goldline Pharmac falling/rising?

27-May-2026

As of 26-May, Goldline Pharmaceutical Ltd's stock price is Rs. 43.95, down 4.99% and at a new 52-week low. The stock is in a bearish trend, underperforming its sector and experiencing a significant drop in investor participation.

View full answer

Which are the latest news on Goldline Pharmac?

27-May-2026

No latest news for Goldline Pharmac found.

Compare Goldline Pharmac with Similar Stocks

Vista Pharma.Roopa Industries Mangalam Drugs

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 40 Cr (Micro Cap)

P/E

16.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.73

Return on Equity

27.33%

Price to Book

4.08

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Listing of Equity Shares of Goldline Pharmaceutical Ltd

19-May-2026 | Source : BSE

Trading Members of the Exchange are hereby informed that effective from May 19 2026 the Equity Shares of Goldline Pharmaceutical Ltd (Scrip Code: 544759) are listed and admitted to dealings on the Exchange in the list of MT Group Securities. For further details please refer to the notice no. 20260518- dated May 18 2026.

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

2.91

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

26.42%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.97%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.28

EV to EBIT

9.28

EV to EBITDA

8.89

EV to Capital Employed

2.89

EV to Sales

1.85

PEG Ratio

Dividend Yield

ROCE (Latest)

31.13%

ROE (Latest)

27.33%

Technicals key factors

Indicator

Weekly

Monthly

Technical indicator has not been calculated since the stock has been active for a short period

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : May 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 15 FIIs (5.16%)

Promoter with highest holding

Amol Laxmikant Mujumdar (28.65%)

Highest Public shareholder

Sumit Bilgaiyan (7.03%)

Individual Investors Holdings

25.14%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Goldline Pharmac"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Goldline Pharmac"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Goldline Pharmac"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Goldline Pharmac"
  }
]

Company CV

About Goldline Pharmaceutical Ltd

Goldline Pharmaceutical Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of `Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to `Goldline Pharmaceutical Limited' w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.

Company Coordinates

No Company Details Available